Skip to main content
. Author manuscript; available in PMC: 2013 Feb 10.
Published in final edited form as: Cancer. 2010 Oct 11;116(23):5517–5526. doi: 10.1002/cncr.25502

Table 4.

Results of univariate analysis of clinicopathological parameters and the expression levels of six mTOR related biomarkers in relations to disease specific survival, overall survival and disease progression. Pten: phosphatase and tensine homologue; p27: p27kip; phos Akt: phoporylated Akt; phos S6: phosphorylated S6 protein; 4E-BP1: eukaryotic translation initiation factor 4E-binding protein-1. NS: not significant.

Univariate Analysis

Outcome

DSS OS Progression
Clinicopathological Parameters

pT p=0.080 p=0.083 p=0.061
TNM stage grouping p=0.007 p=0.024 p=0.039
Organ confined disease status p=0.016 p=0.021 p=0.010
Lymph node status p=0.050 p=NS p=0.010
Lymphovascular invasion p=0.020 p=0.002 p=0.060
Divergent aggressive histology p=0.005 p=0.029 p=0.031
Concomitant CIS p=NS p=0.008 p=NS

mTOR Markers

Pten p=NS p=NS p=NS
Phos Akt p=NS p=NS p=NS
Phos S6 p=0.001 p=0.01 p=0.05
4 EBP-1 p=NS p=NS p=NS
c-Myc p=NS p=NS p=0.01
P27 p=NS p=NS p=NS